HeartSciences (HSCS) Capital Expenditures (2022 - 2024)
HeartSciences (HSCS) posted quarterly Capital Expenditures of $48799.0 for Q2 2024, up 542.77% year-on-year from $7592.0 in Q2 2023, and up 454.91% on a QoQ basis from $8794.0 in Q1 2024.
HeartSciences (HSCS) Capital Expenditures (2022 - 2024) Analysis & Trends
HeartSciences (HSCS) has reported Capital Expenditures for 3 consecutive years, with $48799.0 the latest figure, recorded in Q2 2024.
- Quarterly Capital Expenditures rose 542.77% year-over-year to $48799.0 in Q2 2024, while the trailing twelve-month figure through Apr 2026 was $48799.0 (down 15.27% YoY) and the FY2026 annual result came in at $3554.0, up 12.58% from the prior year.
- Capital Expenditures climbed to $48799.0 in Q2 2024 per HSCS's latest filing, from $8794.0 in the prior quarter.
- Over the last five years, Capital Expenditures for HSCS reached as high as $48799.0 in Q2 2024 and fell as low as $1952.0 in Q4 2023.
- A 3-year average of $11823.3 and a median of $7247.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 32.25% — and 2024, when it jumped 542.77%.
- Year by year, Capital Expenditures stood at $7247.0 in 2022, then sank by 73.06% to $1952.0 in 2023, then jumped by 2399.95% to $48799.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered $48799.0, $8794.0, and $1952.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -85.46 Mn |
| 10 | HeartSciences | 6.46 Mn | 4.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 48,799.00 |
| Apr 30, 2024 | 48,799.00 |
| Jan 31, 2024 | 8,794.00 |
| Jan 31, 2024 | 8,794.00 |
| Oct 31, 2023 | 1,952.00 |
| Oct 31, 2023 | 1,952.00 |
| Jul 31, 2023 | 4,910.00 |
| Jul 31, 2023 | 4,910.00 |
| Apr 30, 2023 | 7,592.00 |
| Apr 30, 2023 | 7,592.00 |
| Jan 31, 2023 | 3,469.00 |
| Jan 31, 2023 | 3,469.00 |
| Jul 31, 2022 | 7,247.00 |
| Jul 31, 2022 | 7,247.00 |